Amundi
GSK icon

Amundi’s GSK GSK Stock Holding History

Amundi’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.5M Sell
63,429
-2,049
-3% -$111K ﹤0.01% 1033
2025
Q4 		$3.21M Buy
+65,478
New +$3.05M ﹤0.01% 1093
2024
Q4 		– Sell
-67,884
Closed -$2.58M – 2167
2024
Q3 		$2.58M Buy
+67,884
New +$2.78M ﹤0.01% 1100
2024
Q2 		– Sell
-14,191
Closed -$557K – 1974
2024
Q1 		$557K Buy
+14,191
New +$585K ﹤0.01% 1399

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Amundi's GSK Position: Q1 2026 in Review

Amundi reduced its GSK (GSK) stake by 3.1% in Q1 2026, selling an estimated $111K and leaving 63,429 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Amundi first reported a position in GSK in Q1 2024 and has held it in 4 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Amundi held 63,429 shares of GSK worth $3.5M as of Q1 2026.
  • Amundi sold 2,049 GSK shares in Q1 2026, an estimated $111K.
  • GSK made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1033 holding.
  • Amundi first reported a position in GSK in Q1 2024 and has held it in 4 quarters since.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.